India's efforts to produce and supply life-saving drugs at affordable prices face challenges from multinational companies trying to “evergreen” their patents. THE average life expectancy across the globe has increased from around 30 years a century ago to over 65 years today. This has been made possible in large part by modern medicine. Never before in history have humans had access to such an array of medicines and devices to...
More »SEARCH RESULT
Water: the looming problem-Prakash Nelliyat
World Water Day is held annually on March 22 to focus attention on the importance of freshwater and advocate sustainable management of freshwater resources. Each year, the day highlights a specific aspect of freshwater and this year's campaign was on “Water and Food Security.” A large quantity of water, more than most people think, is used for producing the food we eat everyday. Water is a renewable and finite resource...
More »Big food brands hide harmful effects, claims Delhi-based NGO Centre for Science and Environment
-The Times of India Delhi-based NGO, Centre for Science and Environment, has alleged that leading food manufacturers are guilty of "large scale misbranding and misinformation" by claiming that their food contained zero trans-fats even though tests showed that they have heavy doses of it. Most popular "junk foods contain very high levels of trans-fats, salts and sugar - which inevitably lead to severe ill health and diseases like obesity and diabetes," the...
More »Natco Pharma bags licence to sell Bayer's cancer drug Nexavar
-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision. The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...
More »Natco Pharma bags licence to sell Bayer's cancer drug Nexavar
-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision. The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...
More »